Phathom Pharmaceuticals Inc (PHAT)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -285.588 | -197.715 | -46.739 | -59.389 | -111.632 | -69.676 |
| Return on Equity (%) | 200.311 | -225.113 | -61.137 | -108.009 | 14877.577 | 273.21 |
| Return on Invested Capital (%) | 190.513 | -85.223 | -51.92 | -67.119 | -182.832 | -465.143 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -23405.279 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -29558.944 |
| Book Value Per Share | -0.212 | 9.218 | 6.813 | 2.365 | -1.804 | -1.271 |
| Earnings Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
| Cash Per Share | 0.145 | 9.858 | 10.082 | 6.006 | 3.747 | 6.662 |
| Working Capital Per Share | -0.212 | 10.185 | 8.271 | 5.493 | 3.238 | 6.264 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.009 |
| EBIT Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
| EBITDA Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
| Free Cash Flow Per Share | -0.213 | -9.297 | -4.5 | -4.722 | -4.758 | -3.503 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.412 | 68.197 | 5.248 | 9.858 | 6.118 | 10.248 |
| Quick Ratio | 0.402 | 65.039 | 5.178 | 9.685 | 5.922 | 9.877 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | 646.51 |
| Shares Outstanding | 6.05M | 24.73M | 28.52M | 30.51M | 41.47M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 38.37M | 41.14M | 41.47M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -3435.356 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -4333.264 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 9.682 | N/A | N/A | N/A | 7.831 |
| Quick Ratio | N/A | N/A | N/A | 8.971 | N/A | N/A | N/A | 7.504 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 278.332 |
| Market Cap | 649.16M |
| Price to Earnings Ratio | -3.22 |
| Price to Sales Ratio | 947.86 |
| Price to Cash Ratio | 1.7 |
| Price to Book Ratio | -8.92 |
| Dividend Yield | - |
| Shares Outstanding | 58.54M |
| Average Volume (1 week) | 638.74k |
| Average Volume (1 Month) | 490.33k |
| 52 Week Change | -11.00% |
| 52 Week High | 17.0185 |
| 52 Week Low | 6.065 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
